0000899243-17-017465.txt : 20170628
0000899243-17-017465.hdr.sgml : 20170628
20170628194749
ACCESSION NUMBER: 0000899243-17-017465
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170628
FILED AS OF DATE: 20170628
DATE AS OF CHANGE: 20170628
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Excel Medical Ventures, LLC
CENTRAL INDEX KEY: 0001571999
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 17936532
BUSINESS ADDRESS:
STREET 1: 800 BOYLSTON STREET
STREET 2: SUITE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-450-9800
MAIL ADDRESS:
STREET 1: 800 BOYLSTON STREET
STREET 2: SUITE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Enriquez Juan
CENTRAL INDEX KEY: 0001572090
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 17936533
MAIL ADDRESS:
STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC
STREET 2: 800 BOYLSTON STREET, SUITE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blume Frederick R.
CENTRAL INDEX KEY: 0001572066
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 17936534
MAIL ADDRESS:
STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC
STREET 2: 800 BOYLSTON ST., SUITE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gullans Steven R. Ph.D.
CENTRAL INDEX KEY: 0001571997
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 17936535
MAIL ADDRESS:
STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC
STREET 2: 800 BOYLSTON ST., STE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EXCEL MEDICAL FUND LP
CENTRAL INDEX KEY: 0001428044
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 17936536
BUSINESS ADDRESS:
STREET 1: 800 BOYLSTON STREET
STREET 2: SUITE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-450-9800
MAIL ADDRESS:
STREET 1: 800 BOYLSTON STREET
STREET 2: SUITE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-06-28
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001428044
EXCEL MEDICAL FUND LP
800 BOYLSTON STREET, SUITE 2825
BOSTON
MA
02199
0
0
1
0
0001571997
Gullans Steven R. Ph.D.
800 BOYLSTON STREET, SUITE 2825
BOSTON
MA
02199
0
0
1
0
0001572066
Blume Frederick R.
800 BOYLSTON STREET, SUITE 2825
BOSTON
MA
02199
0
0
1
0
0001572090
Enriquez Juan
800 BOYLSTON STREET, SUITE 2825
BOSTON
MA
02199
0
0
1
0
0001571999
Excel Medical Ventures, LLC
800 BOYLSTON STREET, SUITE 2825
BOSTON
MA
02199
0
0
1
0
Series D Preferred Stock
Common Stock
597167
D
Series E-2 Preferred Stock
Common Stock
133842
D
Series E-3 Preferred Stock
Common Stock
116091
D
Series F Preferred Stock
Common Stock
108998
D
The Series D Preferred Stock is convertible into Common Stock on a 9.937-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
The Series E-2 Preferred Stock is convertible into Common Stock on a 9.937-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
The Series E-3 Preferred Stock is convertible into Common Stock on a 9.937-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
The Series F Preferred Stock is convertible into Common Stock on a 9.937-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P. Steven R. Gullans, Frederick R. Blume and Juan Enriquez are the Managing Directors of Excel Medical Ventures, LLC. Excel Medical Ventures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
/s/ Fredrick R. Blume, Excel Medical Fund, L.P.
2017-06-28
/s/ Steven R. Gullans
2017-06-28
/s/ Fredrick R. Blume
2017-06-28
/s/ Juan Enriquez
2017-06-28
/s/ Fredrick R. Blume, Excel Medical Ventures, LLC.
2017-06-28